wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35078290-CEBC73BC-93FE-46A3-B1CC-B9D4A1FA0950
Q35078290-CEBC73BC-93FE-46A3-B1CC-B9D4A1FA0950
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35078290-CEBC73BC-93FE-46A3-B1CC-B9D4A1FA0950
A combination therapy for KRAS-driven lung adenocarcinomas using lipophilic bisphosphonates and rapamycin
P2860
Q35078290-CEBC73BC-93FE-46A3-B1CC-B9D4A1FA0950
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35078290-CEBC73BC-93FE-46A3-B1CC-B9D4A1FA0950
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b4fd389aef7ed3d0d797a234c42f3fb10a0abde0
P2860
Zoledronic acid potentiates mTOR inhibition and abolishes the resistance of osteosarcoma cells to RAD001 (Everolimus): pivotal role of the prenylation process.